A first-in-class EGFR-directed KRAS G12V selective inhibitor
"EFTX-G12V is highly selective for KRASG12V and exhibits improved therapeutic activity over pan-KRAS targeting"
@ChadPecot @Cancer_Cell #Oncology #MedEd #MedX #TIC2025
Open Access
www.sciencedirect.com/science/arti...













